Neurodevelopmental investigation of the mirror neurone system in children of women receiving opioid maintenance therapy during pregnancy

Addiction

Volumn 108, Issue 1, 2013, Pages 154-160

  Konijnenberg, Carolien ^a   Melinder, Annika ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Buprenorphine; Cognitive development; Methadone; Mirror neurone system; Opioid maintenance therapy; Prenatal exposure

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC AGENT;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; DEVELOPMENTAL DISORDER; DRUG EFFECT; FEMALE; HUMAN; MALE; MATERNAL AGE; MIRROR NEURON; NEUROPSYCHOLOGICAL TEST; NYSTAGMUS; OCULOGRAPHY; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; PRESCHOOL CHILD;

ADULT; ANALYSIS OF VARIANCE; BUPRENORPHINE; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; EYE MOVEMENT MEASUREMENTS; FEMALE; HUMANS; MALE; MATERNAL AGE; METHADONE; MIRROR NEURONS; NARCOTICS; NEUROPSYCHOLOGICAL TESTS; NYSTAGMUS, PATHOLOGIC; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84871695785     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2012.04006.x     Document Type: Article

References (34)

1. Treatment CfSA. Medication-assisted treatment for opioid addiction in opioid treatment programs. Treatment Improvement Protocol (TIP) Series 43. DHHS Publication no. (SMA) 05-4048. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2005.
2. Fischer G., Johnson R. E., Eder H., Jagsch R., Peternell A., Weninger M. etal. Treatment of opioid-dependent pregnant women with buprenorphine. Addiction 2000; 95: 239-244.
3. Svikis D. S., Lee J. H., Haug N. A., Stitzer M. L. Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drug dependent women. Drug Alcohol Depend 1997; 48: 33-41.
4. Nanovskaya T., Deshmukh S., Brooks M., Ahmed M. S. Transplacental transfer and metabolism of buprenorphine. J Pharmacol Exp Ther 2002; 300: 26-33.
5. Jones H. E., Kaltenbach K., Heil S. H., Stine S. M., Coyle M. G., Arria A. M. etal. Neonatal abstinence syndrom after methadone or buprenorphine exposure. N Engl J Med 2010; 363: 2320-2331.
6. Van Baar A., de Graaff B. M. T. Cognitive development at preschool-age of infants of drug-dependent mothers. Dev Med Child Neurol 1994; 36: 1063-1075.
7. Bauman P. S., Levine S. A. The development of children of drug addicts. Int J Addict 1986; 21: 849-863.
8. Salo S., Kivistö K., Korja R., Biringen Z., Tupola S., Kahila H. etal. Emotional availability, parental self-efficacy beliefs, and child development in caregiver-child relationships with buprenorphine-exposed 3-year-olds. Parent Sci Pract 2009; 9: 244-259.
9. Konijnenberg C., Melinder A. Prenatal exposure to methadone and buprenorphine: a review of the potential effects on cognitive development. Child Neuropsychol 2011; 17: 495-519.
10. Rizzolatti G. The mirror neuron system and its function in humans. Anat Embryol (Berl) 2005; 210: 419-421.
11. Iacoboni M., Dapretto M. The mirror neuron system and the consequences of its dysfunction. Nat Rev Neurosci [10.1038/nrn2024]. 2006; 7: 942-951.
12. Gredebäck G., Melinder A. Infants' understanding of everyday social interactions: a dual process account. Cognition 2010; 114: 197-206.
13. Ohnishi T., Moriguchi Y., Matsuda H., Mori T., Hirakata M., Imabayashi E. etal. The neural network for the mirror system and mentalizing in normally developed children: an fMRI study. Neuroreport 2004; 15: 1483-1487.
14. Hans S. L. Developmental consequences of prenatal exposure to methadonea. Ann NY Acad Sci 1989; 562: 195-207.
15. Johnson H. L., Diano A., Rosen T. S. 24-month neurobehavioral follow-up of children of methadone-maintained mothers. Infant Behav Dev 1984; 7: 115-123.
16. Wilson G. S. Clinical studies of infants and children exposed prenatally to heroin . Ann NY Acad Sci 1989; 562: 183-194.
17. Rizzolatti G., Craighero L. The mirror-neuron system. Annu Rev Neurosci 2004; 27: 169-192.
18. Hamilton R., McGlone L., MacKinnon J. R., Russell H. C., Bradnam M. S., Mactier H. Ophthalmic, clinical and visual electrophysiological findings in children born to mothers prescribed substitute methadone in pregnancy. Br J Ophthalmol 2010; 94: 696-700.
19. Bakstad B., Sarfi M., Welle-Strand G. K., Ravndal E. Opioid maintenance treatment during pregnancy: occurrence and severity of neonatal abstinence syndrome. Eur Addict Res 2009; 15: 128-134.
20. Falck-Ytter T., Gredeback G., von Hofsten C. Infants predict other people's action goals. Nat Neurosci [10.1038/nn1729]. 2006; 9: 878-879.
21. Korkman M. Nepsy: Neuropsykologisk Bedömning 3: 10-12:11 År [NEPSY: A developmental neuropsychological assessment]. Handbok. Stockholm: Psykologiförlaget AB; 2000.
22. Brannigan G. G., Decker S. L. Bender Visual-Motor Gestalt Test, 2nd edn. Rolling Meadows, IL: Riverside Publishing; 2003.
23. Clements W. A., Perner J. Implicit understanding of belief. Cogn Dev 1994; 9: 377-395.
24. Melinder A., Endestad T. O. R., Magnussen S. Relations between episodic memory, suggestibility, theory of mind, and cognitive inhibition in the preschool child. Scand J Psychol 2006; 47: 485-495.
25. Perner J., Leekam S. R., Wimmer H. Three-year-olds' difficulty with false belief: the case for a conceptual deficit. Br J Dev Psychol 1987; 5: 125-137.
26. Mulvihill A. O., Cackett P. D., George N. D., Fleck B. W. Nystagmus secondary to drug exposure in utero. Br J Ophthalmol 2007; 91: 613-615.
27. Whitham J. N., Spurrier N. J., Sawyer M. G., Baghurst P. A., Taplin J. E., White J. M. etal. The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials. Neurotoxicol Teratol 2010; 32: 280-288.
28. Taylor M. J., McCullouch D. L. Visual evoked potentials in infants and children. J Clin Neurophysiol 1992; 9: 357-372.
29. Grissmer D., Grimm K. J., Aiyer S. M., Murrah W. M., Steele J. S. Fine motor skills and early comprehension of the world: two new school readiness indicators. Dev Psychol 2010; 46: 1008-1017.
30. Bhutta A. T., Cleves M. A., Casey P. H., Cradock M. M., Anand K. J. S. Cognitive and behavioral outcomes of school-aged children who were born preterm. JAMA 2002; 288: 728-737.
31. Hack M., Klein N. K., Taylor H. G. Long-term developmental outcomes of low birth weight infants. Future Child 1995; 5: 176-196.
32. Kandall S. R., Albin S., Lowinson J., Berle B., Eidelman A. I., Gartner L. M. Differential effects of maternal heroin and methadone use on birthweight. Pediatrics 1976; 58: 681-685.
33. Robinson S. E., Maher J. R., Wallace M. J., Kunko P. M. Perinatal methadone exposure affects dopamine, norepinephrine, and serotonin in the weanling rat. Neurotoxicol Teratol 1997; 19: 295-303.
34. Robinson S. E., Mo Q., Maher J. R., Wallace M. J., Kunko P. M. Perinatal exposure to methadone affects central cholinergic activity in the weanling rat. Drug Alcohol Depend 1996; 41: 119-126.